# OnCo record targeted-axillary-dissection-md-anderson (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/targeted-axillary-dissection-md-anderson/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "targeted-axillary-dissection-md-anderson" ;
  schema:name "Targeted axillary dissection (MD Anderson prospective study)"@en ;
  schema:alternateName "TAD study"@en, "clipped node study"@en ;
  schema:description "The fix for the problem Z1071 exposed. If the surgeon puts a marker in the lymph node that was biopsied at diagnosis and then goes back for that exact node after chemotherapy, the chance of missing leftover cancer falls from about one in ten to about one in fifty."@en ;
  schema:url <https://onco.cc/trials/targeted-axillary-dissection-md-anderson/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2015.64.0094> ;
  onco:status "positive" ;
  onco:phase "observational" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/fluorescence-guided-surgery/> ;
  onco:terms <https://onco.cc/terms/targeted-axillary-dissection/>, <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/terms/neoadjuvant-versus-adjuvant-breast/> ;
  onco:trials <https://onco.cc/trials/acosog-z1071/>, <https://onco.cc/trials/atnec/> .